Impact BioMedical, Correlations
IBO Stock | USD 1.48 0.08 5.13% |
The current 90-days correlation between Impact BioMedical, and Eagle Capital Growth is -0.17 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Impact BioMedical, Correlation With Market
Very good diversification
The correlation between Impact BioMedical, and DJI is -0.23 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Impact BioMedical, and DJI in the same portfolio, assuming nothing else is changed.
Impact |
Moving together with Impact Stock
Moving against Impact Stock
0.46 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
0.41 | AZN | AstraZeneca PLC ADR | PairCorr |
0.4 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.67 | BA | Boeing Earnings Call This Week | PairCorr |
0.51 | JPHLF | Japan Post Holdings | PairCorr |
0.43 | IBM | International Business Earnings Call This Week | PairCorr |
Related Correlations Analysis
-0.2 | 0.39 | 0.31 | -0.28 | IPB | ||
-0.2 | -0.2 | -0.34 | -0.2 | GRF | ||
0.39 | -0.2 | 0.72 | -0.25 | NBO | ||
0.31 | -0.34 | 0.72 | -0.28 | NBW | ||
-0.28 | -0.2 | -0.25 | -0.28 | ELLO | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Impact Stock performing well and Impact BioMedical, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Impact BioMedical,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IPB | 1.42 | (0.02) | 0.00 | (0.06) | 0.00 | 3.09 | 9.37 | |||
GRF | 1.56 | (0.02) | 0.00 | 0.18 | 0.00 | 4.06 | 12.36 | |||
NBO | 0.53 | 0.00 | (0.03) | 0.33 | 0.73 | 0.87 | 3.54 | |||
NBW | 0.41 | 0.01 | (0.03) | 0.45 | 0.50 | 0.74 | 2.53 | |||
ELLO | 2.16 | 0.48 | 0.19 | 3.45 | 1.96 | 6.18 | 15.02 |